READ THE FULL HITI RESEARCH REPORT
Increased Guidance Announcement
On August 4th, High Tide (NASDAQ: HITI) released updated guidance related to anticipated results for its 3rd fiscal quarter ended July 31, 2026.
The quarter’s new guidance highlights the growing earnings power of High Tide’s global platform. Management expects to set new company records for revenue, gross profit and Adjusted EBITDA, with year-over-year growth of at least 30%, 27% and 43%, respectively. Notably, even the low end of guidance exceeds the highest current analyst estimate across all three metrics, suggesting current market expectations have yet to catch up with the strength, scale and operating leverage of the overall business.
This performance is driven by two increasingly powerful growth engines. In Canada, the company’s bricks-and-mortar retail business returned to positive year-over-year same-store sales in June and sustained that momentum through July, a trend management believes compares favorably with broader market conditions and reflects the strength of its discount-club model. In Germany, Remexian set another all-time quarterly distribution record, shipping over 10 tonnes of medical cannabis, up 33% sequentially and 60% year-over-year. Together, these results point to a strengthening Canadian retail platform alongside a rapidly scaling German medical cannabis business, creating a more diversified and increasingly profitable global enterprise.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
